Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests-How Does the Infotechnomics Compare to Other "Omics" in the Cosmetics Safety Assessment?
- PMID: 37047774
- PMCID: PMC10094956
- DOI: 10.3390/ijms24076801
Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests-How Does the Infotechnomics Compare to Other "Omics" in the Cosmetics Safety Assessment?
Abstract
The aim of the current study was to develop an in silico model to predict the sensitizing potential of cosmetic ingredients based on their physicochemical characteristics and to compare the predictions with historical animal data and results from "omics"-based in vitro studies. An in silico model was developed with the use of WEKA machine learning software fed with physicochemical and structural descriptors of haptens and trained with data from published epidemiological studies compiled into estimated odds ratio (eOR) and estimated attributable risk (eAR) indices. The outcome classification was compared to the results of animal studies and in vitro tests. Of all the models tested, the best results were obtained for the Naive Bayes classifier trained with 24 physicochemical descriptors and eAR, which yielded an accuracy of 86%, sensitivity of 80%, and specificity of 90%. This model was subsequently used to predict the sensitizing potential of 15 emerging and less-studied haptens, of which 7 were classified as sensitizers: cyclamen aldehyde, N,N-dimethylacrylamide, dimethylthiocarbamyl benzothiazole sulphide, geraniol hydroperoxide, isobornyl acrylate, neral, and prenyl caffeate. The best-performing model (NaiveBayes eAR, 24 parameters), along with an alternative model based on eOR (Random Comittee eOR, 17 parameters), are available for further tests by interested readers. In conclusion, the proposed infotechnomics approach allows for a prediction of the sensitizing potential of cosmetic ingredients (and possibly also other haptens) with accuracy comparable to historical animal tests and in vitro tests used nowadays. In silico models consume little resources, are free of ethical concerns, and can provide results for multiple chemicals almost instantly; therefore, the proposed approach seems useful in the safety assessment of cosmetics.
Keywords: contact allergy; cosmetic ingredients; in silico modelling; infotechnomics; risk assessment; sensitizing potential.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Current opinion on risk assessment of cosmetics.J Toxicol Environ Health B Crit Rev. 2021 May 19;24(4):137-161. doi: 10.1080/10937404.2021.1907264. Epub 2021 Apr 8. J Toxicol Environ Health B Crit Rev. 2021. PMID: 33832410 Review.
-
In vitro testing strategy for assessing the skin sensitizing potential of "difficult to test" cosmetic ingredients.Toxicol In Vitro. 2020 Jun;65:104781. doi: 10.1016/j.tiv.2020.104781. Epub 2020 Jan 27. Toxicol In Vitro. 2020. PMID: 32001296
-
Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.Int J Pharm. 2017 Mar 15;519(1-2):178-185. doi: 10.1016/j.ijpharm.2017.01.024. Epub 2017 Jan 16. Int J Pharm. 2017. PMID: 28104405 Review.
-
Skin sensitisation testing in practice: Applying a stacking meta model to cosmetic ingredients.Toxicol In Vitro. 2020 Aug;66:104831. doi: 10.1016/j.tiv.2020.104831. Epub 2020 Mar 18. Toxicol In Vitro. 2020. PMID: 32198056
-
Method for detecting the reactivity of chemicals towards peptides as an alternative test method for assessing skin sensitization potential.Toxicol Lett. 2014 Feb 10;225(1):185-91. doi: 10.1016/j.toxlet.2013.12.007. Epub 2013 Dec 19. Toxicol Lett. 2014. PMID: 24362008
Cited by
-
Evaluation of the Safety of Cosmetic Ingredients and Their Skin Compatibility through In Silico and In Vivo Assessments of a Newly Developed Eye Serum.Toxics. 2024 Jun 22;12(7):451. doi: 10.3390/toxics12070451. Toxics. 2024. PMID: 39058103 Free PMC article.
-
Artificial Intelligence in the Evolution of Customized Skincare Regimens.Cureus. 2025 Apr 18;17(4):e82510. doi: 10.7759/cureus.82510. eCollection 2025 Apr. Cureus. 2025. PMID: 40385841 Free PMC article. Review.
-
Diseases from the Spectrum of Dermatitis and Eczema: Can "Omics" Sciences Help with Better Systematics and More Accurate Differential Diagnosis?Int J Mol Sci. 2023 Jun 21;24(13):10468. doi: 10.3390/ijms241310468. Int J Mol Sci. 2023. PMID: 37445645 Free PMC article. Review.
-
Caffeine as an Active Ingredient in Cosmetic Preparations Against Hair Loss: A Systematic Review of Available Clinical Evidence.Healthcare (Basel). 2025 Feb 12;13(4):395. doi: 10.3390/healthcare13040395. Healthcare (Basel). 2025. PMID: 39997270 Free PMC article. Review.
References
-
- The European Parliament and the Council of the European Union Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. [(accessed on 27 March 2023)];Off. J. Eur. Union. 2009 L 342:59. Available online: https://health.ec.europa.eu/system/files/2016-11/cosmetic_1223_2009_regu....
-
- Reeder M.J., Warshaw E., Aravamuthan S., Belsito D.V., Geier J., Wilkinson M., Atwater A.R., White I.R., Silverberg J.I., Taylor J.S., et al. Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe. JAMA Dermatol. 2023;159:267–274. doi: 10.1001/jamadermatol.2022.5991. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical